Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    CYBA
Show Display Options
Rank Status Study
1 Completed Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy
Conditions: Type 1 Diabetes Mellitus;   Diabetic Nephropathy
2 Unknown  NADPH Oxidase Polymorphisms in Obstructive Sleep Apnea Syndrome (OSAS)
Conditions: Sleep Apnea Syndrome;   Oxidative Stress;   Single Nucleotide Polymorphism
3 Completed Effect of Candesartan in Alcoholic Liver Fibrosis
Condition: Alcoholic Liver Disease
Intervention: Drug: candesartan for hepatic fibrosis

Indicates status has not been verified in more than two years